I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Jhaveri, Komal L.
127
results:
Search for persons
X
Format
Online (127)
Mediatypes
Articles (Online) (52)
OpenAccess-fulltext (75)
Sorted by: Year
Sorted by: Relevance
?
1
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in..:
Bardia, Aditya
;
Jhaveri, Komal
;
Kalinsky, Kevin
...
Future Oncology. 20 (2024) 8 - p. 423-436 , 2024
Link:
https://doi.org/10.2217/..
?
2
NVTG-07 SAFETY, TOLERABILITY, AND ANTITUMOR ACTIVITY OF TRA..:
Anders, Carey
;
Loi, Sherene
;
Hamilton, Erika
...
Neuro-Oncology Advances. 6 (2024) Supplement_1 - p. i25-i25 , 2024
Link:
https://doi.org/10.1093/..
?
3
Current and emerging treatment approaches for hormone recep..:
Jhaveri, Komal
;
Marmé, Frederik
Cancer Treatment Reviews. 123 (2024) - p. 102670 , 2024
Link:
https://doi.org/10.1016/..
?
4
Supplementary Figure S3 from Phase Ia/b Study of Giredestra..:
Komal L. Jhaveri
;
Meritxell Bellet
;
Nicholas C. Turner
...
doi:10.1158/1078-0432.25232186.v1. , 2024
Link:
https://doi.org/10.1158/..
?
5
Supplementary Table S4 from Phase Ia/b Study of Giredestran..:
Komal L. Jhaveri
;
Meritxell Bellet
;
Nicholas C. Turner
...
doi:10.1158/1078-0432.25232174.v1. , 2024
Link:
https://doi.org/10.1158/..
?
6
Supplementary Table S3 from Phase Ia/b Study of Giredestran..:
Komal L. Jhaveri
;
Meritxell Bellet
;
Nicholas C. Turner
...
doi:10.1158/1078-0432.25232177.v1. , 2024
Link:
https://doi.org/10.1158/..
?
7
Supplementary Table S1 from Phase Ia/b Study of Giredestran..:
Komal L. Jhaveri
;
Meritxell Bellet
;
Nicholas C. Turner
...
doi:10.1158/1078-0432.25232183.v1. , 2024
Link:
https://doi.org/10.1158/..
?
8
Supplementary Figure S1 from Phase Ia/b Study of Giredestra..:
Komal L. Jhaveri
;
Meritxell Bellet
;
Nicholas C. Turner
...
doi:10.1158/1078-0432.25232192.v1. , 2024
Link:
https://doi.org/10.1158/..
?
9
Supplementary Figure S2 from Phase Ia/b Study of Giredestra..:
Komal L. Jhaveri
;
Meritxell Bellet
;
Nicholas C. Turner
...
doi:10.1158/1078-0432.25232189.v1. , 2024
Link:
https://doi.org/10.1158/..
?
10
Supplementary Table S2 from Phase Ia/b Study of Giredestran..:
Komal L. Jhaveri
;
Meritxell Bellet
;
Nicholas C. Turner
...
doi:10.1158/1078-0432.25232180.v1. , 2024
Link:
https://doi.org/10.1158/..
?
11
Supplementary Table S5 from Phase Ia/b Study of Giredestran..:
Komal L. Jhaveri
;
Meritxell Bellet
;
Nicholas C. Turner
...
doi:10.1158/1078-0432.25232171.v1. , 2024
Link:
https://doi.org/10.1158/..
?
12
Antitumour activity of neratinib in patients with HER2-muta..:
Harding, James J.
;
Piha-Paul, Sarina A.
;
Shah, Ronak H.
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
13
Molecularly Targeted Therapies for Triple Negative Breast C..:
Mai, Nicholas
;
Abuhadra, Nour
;
Jhaveri, Komal
Clinical Breast Cancer. 23 (2023) 8 - p. 784-799 , 2023
Link:
https://doi.org/10.1016/..
?
14
Novel endocrine therapies: What is next in estrogen recepto..:
Corti, Chiara
;
De Angelis, Carmine
;
Bianchini, Giampaolo
...
Cancer Treatment Reviews. 117 (2023) - p. 102569 , 2023
Link:
https://doi.org/10.1016/..
?
15
Overall survival with sacituzumab govitecan in hormone rece..:
Rugo, Hope S
;
Bardia, Aditya
;
Marmé, Frederik
...
The Lancet. 402 (2023) 10411 - p. 1423-1433 , 2023
Link:
https://doi.org/10.1016/..
1-15
